Valuation (33%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 99.55 | N/A |
| PEG Ratio (TTM) | -6.30 | N/A |
| P/S Ratio (TTM) | 4.03 | N/A |
| P/B Ratio (TTM) | 1.49 | N/A |
| P/FCF Ratio (TTM) | -47.58 | N/A |
| Price to 5YR AVG Earnings Ratio | 25.76 | N/A |
| Price to 5YR AVG FCF Ratio | 20.24 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.15% | N/A |
| ROE (TTM) | 1.54% | N/A |
| Net Profit Margin (TTM) | 3.93% | N/A |
| ROIC 5YR AVG | 5.15% | N/A |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 95.72% | 73.45% | 31.24% |
| Revenue | 13.76% | 13.78% | 5.82% |
| Net Income | 95.92% | 68.58% | 28.25% |
| Cash Flow | -69.06% | 54.50% | 27.24% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 1.32 | N/A |
| Interest Coverage (TTM) | 0.12 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 1.26 | N/A |
| LTL to 5YR AVG FCF | 7.75 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.60% | N/A |